Eli Lilly and Company vs Accenture plc
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while Accenture plc (ACN) is "Neutral" with +8.3% revenue growth. Both companies report in the Healthcare and Technology sectors.
| Metric | Eli Lilly and Company (LLY) | Accenture plc (ACN) |
|---|---|---|
| Operator Signal | Tailwind | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $19.8B | $18.0B |
| Revenue Growth | 73.1%* | 8.3% |
| Latest EPS | $8.26* | $2.93 |
| EPS Growth | 672.0%* | 3.9% |
| Sector | Healthcare | Technology |
| Quarters Tracked | 8 | 8 |
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while Accenture plc (ACN) is "Neutral" with +8.3% revenue growth. Both companies report in the Healthcare and Technology sectors.